Clinical trials
Recruiting Alzheimer Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 9 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 3 |
| Alnylam Pharmaceuticals | 2 |
| Bristol-Myers Squibb | 2 |
| AC Immune SA | 1 |
| Alzheimercentrum Amsterdam | 1 |
| Denali Therapeutics Inc. | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Stichting International Registry for Alzheimer's Disease and other Dementias Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 15 |
| Dementia | 7 |
| Cognitive Dysfunction | 3 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Cardiomyopathies | 1 |
| Frontotemporal Dementia | 1 |
| Heart Diseases | 1 |
| Polyneuropathies | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.